Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy
2001 · Journal of Clinical Investigation · 484 citations
https://doi.org/10.1172/jci13350
H
Hironori Nakagami
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
399
Papers
11.7K
Citations
55
h-index
173
i10-index
Hironori Nakagami is an academic researcher from Osaka Health Science University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Atherosclerosis and Cardiovascular Diseases & Angiogenesis and VEGF in Cancer. The author has an h-index of 55, co-authored 340 publications.
ORCID: 0000-0003-4494-3601Papers by this author
worksVentricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2
2002 · Proceedings of the National Academy of Sciences · 172 citations
https://doi.org/10.1073/pnas.252648999
Low alpha-synuclein levels in the blood are associated with insulin resistance
2015 · Scientific Reports · 43 citations
https://doi.org/10.1038/srep12081
Stable Immune Response Induced by Intradermal DNA Vaccination by a Novel Needleless Pyro-Drive Jet Injector
2019 · AAPS PharmSciTech · 40 citations
https://doi.org/10.1208/s12249-019-1564-z
SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals
2021 · Scientific Reports · 39 citations
https://doi.org/10.1038/s41598-021-85202-9
A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke
2016 · Scientific Reports · 37 citations
https://doi.org/10.1038/srep38062
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat